13D Filing: Muneer A Satter and Vital Therapies Inc (NASDAQ:VTL)

Page 2 of 8 – SEC Filing


SCHEDULE 13D

CUSIP No. 92847R104 Page
2
of 8

Explanatory Note: The Reporting Person has previously filed statements on
Schedule 13G with respect to his ownership of the Issuers common stock. As a result of the recent purchase of shares in the Issuers registered public offering described in this Schedule 13D, the Reporting Person acquired more than 2% of
the Issuers outstanding common stock during the past 12 months and, therefore, is no longer eligible to report his ownership of common stock on Schedule 13G on an annual basis.

  (1)

Names of
reporting persons

Muneer A. Satter

  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐

  (3)

SEC use only

  (4)

Source of funds (see instructions)

PF; OO

  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)

  (6)

Citizenship or place of
organization

United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

  (7)

Sole voting power

11,034,688 shares (see Item 5(a))

  (8)

Shared voting power

0 shares

  (9)

Sole dispositive power

11,034,688 shares (see Item 5(a))

(10)

Shared dispositive power

0 shares

(11)

Aggregate amount beneficially owned by each reporting person

11,034,688 shares (see Item 5(a))

(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)

(13)

Percent of class represented by amount
in Row (11)

26.9%

(14)

Type of reporting person (see
instructions)

IN

Follow Immunic Inc. (NASDAQ:IMUX)